Last year, the pharma industry’ biggest trade group raised a fortune to change the conversation about drug pricing.
It would require pharma companies to charge fair prices for drugs that result from federally funded research.
And we waste billions of dollars thinking otherwise.
A group of shareholders wants the company's directors gone.
Drug prices are a huge burden on Americans’ wallets—and, you know, their health.
Diabetics stretching their doses should be scared of the GOP’s health plan.
Kind of like a password-cracking tool.
A bill being voted on next week would lower prices on the essential drug.